Purchase Order 75F40119P10176
- Not listed
- This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The $63,750.00 firm-fixed-price purchase order is for VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTIONS and PHENOPLEX SOFTWARE UPGRADES. The contract did not utilize a set-aside designation. Visiopharm Corporation is a wholly-owned...
- Visiopharm Corporation, a foreign-owned for-profit organization, was awarded a $24,775.60 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software with a completion date of February 14, 2025. The award was made on February 15, 2024 without a set-aside designation. Visiopharm will provide its precision pathology software for research and diagnostics, leveraging over 20 years of experience...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20, a civilian agency, to Visiopharm Corporation, a foreign-owned for-profit organization. The contract is for VISIOPHARM EXERCISE OPTION YEAR 2 and has a ceiling value of $12,600.00. Visiopharm Corporation is a wholly-owned subsidiary of Visiopharm A/S, a Danish company specializing in precision pathology software and digital microscopy solutions. This contract is not associated with a larger vehicle...
- This is a $86,000.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs to Visiopharm Corporation, a foreign-owned for-profit organization based in Denmark. The contract is for the provision of TISSUEARRAY, PHENOMAP, and AI SOFTWARE ADD ON products and services. Visiopharm Corporation, through this contract, will supply digital pathology software, digital microscopes, and biomarker analysis systems to support...
- The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, awarded a purchase order contract to Visiopharm Corporation, a foreign-owned, for-profit organization, for a VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTION. The firm-fixed-price contract has a ceiling value of $68,800.00 and a period of performance ending on July 31, 2025. Visiopharm Corporation, which specializes in precision pathology software and digital microscopy solutions, has previously secured multiple...
- The National Institute of Environmental Health Sciences (NIEHS) awarded a $83,797.00 firm-fixed-price purchase order to Visiopharm Corporation, a foreign-owned for-profit organization based in Denmark, for IMAGE ANALYSIS SOFTWARE - VISIOPHARM. This sole-source award was made under simplified acquisition procedures without the use of any set-aside. Visiopharm provides precision pathology software and digital microscopy solutions for federal agencies, including VISIOPHARM DIGITAL PATHOLOGY...
- This $79,800.00 firm-fixed-price purchase order from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) awarded to Visiopharm Corporation, a foreign-owned for-profit organization, provides 12-month licenses for Visiopharm's AI-powered image analysis software, Octotopix, and Translational Research Software. The software will support digital pathology and assist pathologists at the NCI's Laboratory of Pathology in analyzing patient tissue samples and providing more...
- The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, awarded a firm-fixed-price purchase order contract to Visiopharm Corporation, a foreign-owned, for-profit organization, for the PHENOPLEX SOFTWARE UPGRADE project. The $46,007.55 contract does not utilize any set-aside designations and has an ultimate completion date of July 31, 2025. Visiopharm Corporation, a provider of precision pathology software and digital microscopy solutions, has secured...
- The U.S. Defense Health Agency (DHA) awarded a $82,190.00 firm-fixed-price purchase order contract to Visiopharm Corporation for the procurement of OCUS40 digital microscopes. The contract has a completion date of October 29, 2023 and was set aside for total small business participation. Visiopharm Corporation is a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions, and is a wholly-owned subsidiary of the manufacturer Visiopharm...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a firm fixed-price purchase order to Visiopharm Corporation, a foreign-owned for-profit organization, for a 3 Biomarker Analysis System. The contract has a potential value of $168,584.91 and a completion date of June 29, 2022. The original procurement was a pre-solicitation announcement seeking Biomarker analysis systems that can detect several forms of cancer using algorithm PD-L1...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The contract is for VISIOPHARM SOFTWARE MAINTENANCE, with a ceiling value of $31,600.00 and a period of performance ending on April 30, 2024. The contract was not set aside for any specific business category. Visiopharm Corporation is a wholly-owned subsidiary of Visiopharm A/S, a Danish company that has over 20 years of experience in developing artificial intelligence and deep learning solutions for digital pathology. Through this and other federal contract awards, Visiopharm has supplied a range of specialized products and services, including digital pathology software, digital microscopes, and biomarker analysis systems, to various government health and research institutions such as the National Cancer Institute, National Institute of Environmental Health Sciences, Defense Health Agency, and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | $0 | 5/23/25 | |
| P00003 | Exercise an Option | $7.9k | 1/28/22 | |
| P00002 | Exercise an Option | $7.9k | 3/16/21 | |
| P00001 | Exercise an Option | $7.9k | 1/13/20 | |
| Not listed | Not listed | $7.9k | 5/15/19 |